Literature DB >> 27060765

Targeting tumor microenvironment in cancer therapy.

Shree Ram Singh1, Pranela Rameshwar2, Peter Siegel3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27060765     DOI： 10.1016/j.canlet.2016.04.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


× No keyword cloud information.
  17 in total

1.  TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation.

Authors:  Sheng-Jun Liao; Jing Luo; Dong Li; Yuan-Hong Zhou; Bin Yan; Jing-Jing Wei; Jian-Cheng Tu; Yi-Rong Li; Gui-Mei Zhang; Zuo-Hua Feng
Journal:  J Cell Commun Signal       Date:  2019-02-09       Impact factor: 5.782

Review 2.  Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.

Authors:  Maryam Tahmasebi Birgani; Vinicio Carloni
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

3.  Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance.

Authors:  Andrej Panic; Julia Ketteler; Henning Reis; Ali Sak; Carsten Herskind; Patrick Maier; Herbert Rübben; Verena Jendrossek; Diana Klein
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

4.  Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.

Authors:  Jiaxing Wang; Fakun Huang; Caiyun Jiang; Pan Chi
Journal:  Med Sci Monit       Date:  2020-04-28

5.  Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.

Authors:  Kavita Radhakrishnan; Adrian M Di Bisceglie; K Rajender Reddy; Joseph K Lim; Josh Levitsky; Mohamed A Hassan; Jama M Darling; Jordan J Feld; Lucy Akushevich; Monika Vainorius; David R Nelson; Michael W Fried; Robert S Brown; Norah A Terrault
Journal:  Hepatol Commun       Date:  2019-08-07

Review 6.  Long Non-coding RNAs as Communicators and Mediators Between the Tumor Microenvironment and Cancer Cells.

Authors:  Di Chen; Tong Lu; Junying Tan; Hao Li; Qiuyue Wang; Liangzhou Wei
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

7.  Transcriptional and Microenvironmental Landscape of Macrophage Transition in Cancer: A Boolean Analysis.

Authors:  Ugo Avila-Ponce de León; Aarón Vázquez-Jiménez; Meztli Matadamas-Guzman; Rosana Pelayo; Osbaldo Resendis-Antonio
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 8.  Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.

Authors:  Emily K Kleczko; Lynn E Heasley
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

9.  Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.

Authors:  Yen-Hsiu Yeh; Ho-Fu Hsiao; Yen-Cheng Yeh; Tien-Wen Chen; Tsai-Kun Li
Journal:  J Exp Clin Cancer Res       Date:  2018-03-27

10.  PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.

Authors:  Hongzhi Du; Yulong Chen; Xiaoying Hou; Yue Huang; Xiaohui Wei; Xiaowen Yu; Shuyun Feng; Yao Wu; Meixiao Zhan; Xin Shi; Sensen Lin; Ligong Lu; Shengtao Yuan; Li Sun
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.